TITLE

HOW EFFECTIVE IS CANCER SURVEILLANCE IN ULCERATIVE COLITIS?

AUTHOR(S)
Rutter, M.D.; Wilkinson, K.H.; Rumbles, S.; Forbes, A.; Saunders, B.P.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA66
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background & Aim: Patients with longstanding extensive ulcerative colitis (UC) are at increased risk of colorectal cancer (CRC). We assessed the value of a long-running colonoscopic surveillance programme. Methods: Patients on biennial colonoscopic surveillance (from 1975 onwards) with histologically proven UC of at least 8 years duration, macroscopically extending proximal to the splenic flexure were included. All patients were followed up to 1/1/01. Data were obtained from our prospective UC surveillance database, medical records & reports, GPs, other hospitals & the Office of National Statistics. Results: 600 patients underwent 2627 colonoscopies & 5080 years of surveillance. 68 patients (11%) had dysplasia or cancer detected during surveillance. Initial dysplasia was Iow-grade (46), high-grade (10), & CRC (12). 89 patients underwent surgery (86 colectomies, 3 partial resections). Fourteen operations were for a preoperative diagnosis of CRC, 16 for HGD (6 cancers in specimens), 14 for LGD (3 cancers in specimens), & one for an adenoma. 44 operations were for symptoms (5 cancers in specimens). In addition, 2 patients died of CRC without surgery. In total, 30 patients developed CRC within the surveillance programme. Of the 25 surveillancedetected CRCs, 15 (60%) were Dukes' A or B. A further 16 patients had colectomies for dysplasia, & had dysplasia confirmed in the colectomy specimen. Thus 31 patients benefited from surveillance. This equates to one benefit per 19 patients, or one benefit per 164 surveillance years. 13 patients presented with Dukes' C or disseminated malignancy within the surveillance programme. Conclusion: The current colonoscopic surveillance programme benefits approximately 3/4 of patients who are likely to develop lifethreatening cancers. However, it requires considerable effort and expense over a prolonged period of time. A significant minority of patients still present with advanced cancer despite surveillance...
ACCESSION #
9747735

 

Related Articles

  • PAN-COLONIC INDIGO CARMINE DYE SPRAYING FOR THE DETECTION OF DYSPLASIA IN ULCERATIVE COLITIS. Rutter, M.D.; Schofield, G.; Price, A.B.; Talbot, I.C.; Saunders, B.P. // Gut;Apr2003 Supplement 1, Vol. 52, pA6 

    Background and Aim: Patients with longstanding extensive ulcerative colitis (UC) are at increased risk of colorectal cancer. Colonoscopic surveillance is often performed, and relies heavily on multiple non-targeted mucosal biopsies detecting occult dysplasia. Chromoendoscopy can aid detection of...

  • Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. Hata, K.; Watanabe, T.; Kazama, S.; Suzuki, K.; Shinozaki, M.; Yokoyama, T.; Matsuda, K.; Muto, T.; Nagawa, H. // British Journal of Cancer;10/6/2003, Vol. 89 Issue 7, p1232 

    Patients with long-standing ulcerative colitis (UC) are known to have an increased risk for the development of colorectal cancer (CRC). The aim of this study was to clarify the cumulative risk for the development of dysplasia or invasive cancer and the effectiveness of surveillance colonoscopy...

  • Safety of Surveillance Colonoscopy in Long-standing Ulcerative Colitis. Koobatian, Gregor J.; Choi, Paul M. // American Journal of Gastroenterology;Sep1994, Vol. 89 Issue 9, p1472 

    Objective: Because of the increased risk of colorectal cancer in patients with long-standing ulcerative colitis, colonoscopic surveillance for the detection of dysplasia is currently recommended as a method of identifying high-risk patients. However, the hazard of colonoscopy with multiple...

  • Evaluation of Mucosal Healing of Ulcerative Colitis by a Quantitative Fecal Immunochemical Test. Nakarai, Asuka; Kato, Jun; Hiraoka, Sakiko; Kuriyama, Motoaki; Akita, Mitsuhiro; Hirakawa, Tomoko; Okada, Hiroyuki; Yamamoto, Kazuhide // American Journal of Gastroenterology;Jan2013, Vol. 108 Issue 1, p83 

    OBJECTIVES:Accumulating evidence has underlined the importance of mucosal healing as a treatment goal for ulcerative colitis (UC). Quantitative fecal immunochemical tests (FITs), which can rapidly quantify fecal blood with automated equipment, have been used recently to screen for colorectal...

  • Optimal Timing of Colonoscopy to Screen for Cancer in Ulcerative Colitis. Lashner, Bret A.; Hanauer, Stephen B.; Silverstein, Marc D. // Annals of Internal Medicine;Feb88, Vol. 108 Issue 2, p274 

    Analyzes the outcomes of mucosal dysplasia or cancer to determine the annual risk of high-grade dysplasia or colon cancer. Risk faced by patients with chronic ulcerative colitis; Characteristics of patients in the colon cancer screening program followed for ulcerative colitis; Basis of...

  • The Effect of Indigocarmine on Improvement of the Polyp Detection Rate during Colonoscopic Examination with Hood Cap. Sang Chang Kwon; Sung Won Choi; Seong Ho Choi; Hee Seung Park; Seung Heon Lee; Bong Gun Kim; Eun Hee Seo; Mun Jang; Seung Min Ryu; Dong Hyun Kim; Young Hoon Kim; Jun Ouk Ha; Jae Seung Lee // Intestinal Research;2014, Vol. 12 Issue 1, p60 

    Background/Aims: Hood cap-assisted chromocolonoscopy using indigocarmine is expected to improve the detection rate of colorectal polyps, especially adenomatous polyps. Therefore, aim of the present study was to evaluate the usefulness of hood cap-assisted chromocolonoscopy in routine...

  • Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort. Matsuoka, Hiroki; Ikeuchi, Hiroki; Uchino, Motoi; Bando, Toshihiro; Takesue, Yoshio; Nishigami, Takayuki; Tomita, Naohiro // International Journal of Colorectal Disease;Jun2013, Vol. 28 Issue 6, p829 

    Purpose: Cancer surveillance has been conducted in patients with ulcerative colitis (UC), and the number of operative cases of ulcerative colitis-associated colorectal cancer (UC-CRC) has been increasing. The aim of this study was to clarify the clinicopathological features and prognoses of...

  • Chemoprevention in Ulcerative Colitis: Narrowing the Gap between Clinical Practice and Research. Hawk, Ernest T.; Viner, Jaye L. // Annals of Internal Medicine;01/16/2001, Vol. 134 Issue 2, p158 

    Editorial. Comments on chemoprevention in ulcerative colitis. Susceptibility of patients with ulcerative colitis to acquire colorectal cancer; Association of fecal bile acids with colorectal cancer; Assessment through colonoscopic surveillance and mucosal biopsy.

  • Ulcerative Colitis: A Clearer Picture. Dworken, Harvey J. // Annals of Internal Medicine;Nov83, Vol. 99 Issue 5, p717 

    Editorial. Presents a study of patients with chronic ulcerative colitis in Scotland. Mortality rate of the disease; Diagnosis of patients; Risk of colonic cancer among patients with the disease.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics